Skip to main content

Table 3 Insulin metrics

From: Associations between bolus infusion of hydrocortisone, glycemic variability and insulin infusion rate variability in critically Ill patients under moderate glycemic control

 

Patients who did not receive bolus infusion of hydrocortisone (N = 5447)

Patients who received infusion of hydrocortisone (N = 962)

P value

Total cohort (N = 6409)

Patients receiving insulin infusion [no (%)]

3693 (67.8)

875 (91.0)

<0.001

4568 (71.3)

Patients receiving boluses of insulin infusion [no (%)]

490 (9.0)

248 (25.8)

<0.001

738 (11.5)

Number of insulin rate adjustments (median [IQR])

3 [0–8]

17 [6–35]

<0.001

4 [0–12]

Median number of insulin rates per day (median [IQR])

1 [0–2]

2 [1–3]

<0.001

1 [0–2]

Median number of insulin rates per day with hydrocortisone (median [IQR])

 

3 [1–4]

  

Median number of insulin rates per day without hydrocortisone (median [IQR])

 

1 [0–2]

  

Patients in insulin infusion rate variability category:

    

 No insulin infusion rate variability

2494 (45.8)

136 (14.1)

 

2630 (41.0)

 Small insulin infusion rate variability

887 (16.3)

111 (11.5)

 

998 (15.6)

 Moderate insulin infusion rate variability

1104 (20.3)

260 (27.0)

 

1364 (21.3)

 High insulin infusion rate variability

962 (17.7)

455 (47.3)

 

1417 (22.1)

Standard deviation of insulin rate (IU/h, median [IQR])

0.6 [0–1.3]

1.6 [0.8–6.2]

<0.001

0.7 [0–1.6]

  1. IQR interquartile range, IU international units